The strengths of this study included an interventional study design and relatively long-term follow-up, a large sample size, and well-characterized metabolic phenotypes of obese populations of both MHO and MUHO subjects (since most of the studies focus on diabetes or insulin-resistant populations). The gene discussed is INS; the disease is diabetes mellitus.